Published July 2, 2021 | Version v2
Journal article Open

Antibody Characterization Report for Serine/threonine-protein kinase TBK1

Creators

  • 1. Montreal Neurological Institute

Description

Head to head comparison of available commercial antibodies against Serine/threonine-protein kinase TBK1 by immunoblot (Western blot), immunoprecipitation and immunofluorescence. The workflow and data collected in this study was used to create an article published on F1000, DOI: 10.12688/f1000research.124632.2. 

This work is part of the ALS-Reproducible Antibody Platform (ALS-RAP). ALS-RAP was created as a public-private partnership by three leading ALS charities - the ALS Association (USA), the Motor Neurone Disease Association (UK), and the ALS Society of Canada.

Files

Serine threonine-protein kinase TBK1_TBK1-YCharOS report_v2.pdf

Files (2.9 MB)